Alan E. Tomkinson

Alan E. Tomkinson

Auto-generated profile, based on publicly available information

Alan E. Tomkinson

Department of Internal Medicine, University of New Mexico, Albuquerque, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ASAnnahita Sallmyr
Annahita Sallmyr
ATAlan E. Tomkinson
Alan E. Tomkinson
Alternative end-joining (alt-EJ) pathways, which repair DNA double-strand breaks (DSBs), are initiated by end resection that generates 3’ single strands. This reaction is shared, at least in part, with homologous recombination but distinguishes alt-EJ from the major nonhomologous end-joining pathway. Although the alt-EJ pathways make only a minor and poorly understood contribution to DSB repair in nonmalignant cells, there is growing interest in these pathways, as they generate genomic rearrangements that are hallmarks of cancer cells. Here, we review and discuss the current understanding of the mechanisms and regulation of alt-EJ pathways, the role of alt-EJ in human disease, and the potential utility of alt-EJ as a therapeutic target in cancer.

14 April 2021 in Nature
Verified
Journal Article
Closed access
PDF file
SCSiyu Chen
Siyu Chen
LLLinda Lee
Linda Lee
TNTasmin Naila
Tasmin Naila
SFSusan Fishbain
Susan Fishbain
AWAnnie Wang
Annie Wang
Yuan HeYuan He
Yuan He

1 September 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JDJulie Della-Maria
Julie Della-Maria
YZYi Zhou
Yi Zhou
MTMiaw-Sheue Tsai
Miaw-Sheue Tsai
JKJeff Kuhnlein
Jeff Kuhnlein
JCJames P. Carney
James P. Carney
ATAlan E. Tomkinson
Alan E. Tomkinson
Recent studies have implicated a poorly defined alternative pathway of nonhomologous end joining (alt-NHEJ) in the generation of large deletions and chromosomal translocations that are frequently observed in cancer cells. Here, we describe an interaction between two factors, hMre11/hRad50/Nbs1 (MRN) and DNA ligase IIIα/XRCC1, that have been linked with alt-NHEJ. Expression of DNA ligase IIIα and the association between MRN and DNA ligase IIIα/XRCC1 are altered in cell lines defective in the major NHEJ pathway. Most notably, DNA damage induced the association of these factors in DNA ligase IV-deficient cells. MRN interacts with DNA ligase IIIα/XRCC1, stimulating intermolecular ligation, and together these proteins join incompatible DNA ends in a reaction that mimics alt-NHEJ. Thus, our results provide novel mechanistic insights into the alt-NHEJ pathway that not only contributes to genome instability in cancer cells but may also be a therapeutic target.

1 July 2016 in DNA Repair
Verified
Journal Article
Closed access
GGGeorge E. Greco
George E. Greco
YMYoshihiro Matsumoto
Yoshihiro Matsumoto
RBRhys C. Brooks
Rhys C. Brooks
ZLZhengfei Lu
Zhengfei Lu
MLMichael R. Lieber
Michael R. Lieber
ATAlan E. Tomkinson
Alan E. Tomkinson

7 July 2012
Verified
Book Chapter
Closed access
PDF file
THTimothy R. L. Howes
Timothy R. L. Howes
ATAlan E. Tomkinson
Alan E. Tomkinson

1 December 2013 in Gene
Verified
Journal Article
Closed access
ATAlan E. Tomkinson
Alan E. Tomkinson
ASAnnahita Sallmyr
Annahita Sallmyr